Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis

American Journal of Human Genetics

Volumn 94, Issue 1, 2014, Pages 47-61

  Mayes, Maureen D ^a   Bossini Castillo, Lara ^b   Gorlova, Olga ^a   Martin, José Ezequiel ^b   Zhou, Xiaodong ^a   Chen, Wei V ^a   Assassi, Shervin ^a   Ying, Jun ^a   Tan, Filemon K ^a   Arnett, Frank C ^a   Reveille, John D ^a   Guerra, Sandra ^c   Teruel, María ^b   Carmona, Francisco David ^b   Gregersen, Peter K ^d   Lee, Annette T ^d   López Isac, Elena ^b   Ochoa, Eguzkine ^b   Carreira, Patricia ^e   Simeón, Carmen Pilar ^f   Castellví, Iván ^g   González Gay, Miguel Ángel ^h   Zhernakova, Alexandra ⁱ   Padyukov, Leonid ^j   Alarcón Riquelme, Marta ^k,l   Wijmenga, Cisca ⁱ   Brown, Matthew ^m   Beretta, Lorenzo ⁿ   Riemekasten, Gabriela ^o   Witte, Torsten ^p   Hunzelmann, Nicolas ^q   Kreuter, Alexander ^r   Distler, Jörg H W ^s   Voskuyl, Alexandre E ^t   Schuerwegh, Annemie J ^u   Hesselstrand, Roger ^v   Nordin, Annika ^j   Airó, Paolo ^w   Lunardi, Claudio ^x   Shiels, Paul ^y   Van Laar, Jacob M ^z   Herrick, Ariane ^aa   Worthington, Jane ^aa   Denton, Christopher ^c   Wigley, Fredrick M ^ab   Hummers, Laura K ^ab   Varga, John ^ac   Hinchcliff, Monique E ^ac   Baron, Murray ^ad   Hudson, Marie ^ad   Pope, Janet E ^ae   Furst, Daniel E ^af   Khanna, Dinesh ^ag   Phillips, Kristin ^ag   Schiopu, Elena ^ag   Segal, Barbara M ^ah   Molitor, Jerry A ^ah   Silver, Richard M ^ai   Steen, Virginia D ^aj   Simms, Robert W ^ak   Lafyatis, Robert A ^ak   Fessler, Barri J ^al   Frech, Tracy M ^am   Alkassab, Firas ^an   Docherty, Peter ^ao   Kaminska, Elzbieta ^ap   Khalidi, Nader ^aq   Jones, Henry Niall ^ar   Markland, Janet ^as   Robinson, David ^at   Broen, Jasper ^au,av   Radstake, Timothy R D J ^au,av   Fonseca, Carmen ^c   Koeleman, Bobby P ^av   Martin, Javier ^b   more..

^a UNIVERSITY OF TEXAS   (United States)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^h HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k UNIVERSITY OF GRANADA   (Spain)

^l OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^m UNIVERSITY OF QUEENSLAND   (Australia)

ⁿ FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^o CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^p HANNOVER MEDICAL SCHOOL   (Germany)

^q UNIVERSITY OF COLOGNE   (Germany)

^r St Elisabeth Hospital   (Germany)

^s UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^t VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^u LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^v LUND UNIVERSITY   (Sweden)

^w SPEDALI CIVILI   (Italy)

^x UNIVERSITY OF VERONA   (Italy)

^y UNIVERSITY OF GLASGOW   (United Kingdom)

^z NEWCASTLE UNIVERSITY   (United Kingdom)

^aa UNIVERSITY OF MANCHESTER   (United Kingdom)

^ab JOHNS HOPKINS UNIVERSITY   (United States)

^ac NORTHWESTERN UNIVERSITY   (United States)

^ad MCGILL UNIVERSITY   (Canada)

^ae UNIVERSITY OF WESTERN ONTARIO   (Canada)

^af UNIVERSITY OF CALIFORNIA   (United States)

^ag UNIVERSITY OF MICHIGAN   (United States)

^ah UNIVERSITY OF MINNESOTA   (United States)

^ai MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^aj GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^ak BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^al UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^am UNIVERSITY OF UTAH   (United States)

^an LEVINE CANCER INSTITUTE   (United States)

^ao MONCTON HOSPITAL   (Canada)

^ap ALBERTA HEALTH SERVICES   (Canada)

^aq MCMASTER UNIVERSITY   (Canada)

^ar University of Edmonton   (Canada)

^as UNIVERSITY OF SASKATCHEWAN   (Canada)

^at UNIVERSITY OF MANITOBA   (Canada)

^au RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^av UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DRB1 ANTIGEN;

AMINO ACID COMPOSITION; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOASSAY; IMMUNOCHIP ANALYSIS; MALE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS;

EID: 84891817885     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2013.12.002     Document Type: Article

References (74)

1. M.B. Bolster, and R.S. Silver Clinical features of systemic sclerosis M.C. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblatt, M.H. Weisman, Rheumatology Fifth Edition 2011 Mosby, Elsevier Philadelphia 1373 1386
2. E.C. LeRoy, C. Black, R. Fleischmajer, S. Jablonska, T. Krieg, T.A. Medsger Jr., N. Rowell, and F. Wollheim Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J. Rheumatol. 15 1988 202 205
3. V.D. Steen Autoantibodies in systemic sclerosis Semin. Arthritis Rheum. 35 2005 35 42
4. J.E. Martín, L. Bossini-Castillo, and J. Martín Unraveling the genetic component of systemic sclerosis Hum. Genet. 131 2012 1023 1037
5. M.D. Mayes The genetics of scleroderma: looking into the postgenomic era Curr. Opin. Rheumatol. 24 2012 677 684
6. S. Assassi, T.R. Radstake, M.D. Mayes, and J. Martin Genetics of scleroderma: implications for personalized medicine? BMC Med. 11 2013 9
7. T.R. Radstake, O. Gorlova, B. Rueda, J.E. Martin, B.Z. Alizadeh, R. Palomino-Morales, M.J. Coenen, M.C. Vonk, A.E. Voskuyl, A.J. Schuerwegh Spanish Scleroderma Group Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus Nat. Genet. 42 2010 426 429
8. Y. Allanore, M. Saad, P. Dieudé, J. Avouac, J.H. Distler, P. Amouyel, M. Matucci-Cerinic, G. Riemekasten, P. Airo, and I. Melchers et al. Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis PLoS Genet. 7 2011 e1002091
9. O. Gorlova, J.E. Martin, B. Rueda, B.P. Koeleman, J. Ying, M. Teruel, L.M. Diaz-Gallo, J.C. Broen, M.C. Vonk, C.P. Simeon Spanish Scleroderma Group Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy PLoS Genet. 7 2011 e1002178
10. L. Bossini-Castillo, J.E. Martin, J. Broen, C.P. Simeon, L. Beretta, O.Y. Gorlova, M.C. Vonk, N. Ortego-Centeno, G. Espinosa, P. Carreira Spanish Scleroderma Group Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study Ann. Rheum. Dis. 72 2013 602 607
11. L. Bossini-Castillo, J.E. Martin, J. Broen, O. Gorlova, C.P. Simeón, L. Beretta, M.C. Vonk, J.L. Callejas, I. Castellví, P. Carreira Spanish Scleroderma Group A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations Hum. Mol. Genet. 21 2012 926 933
12. J.E. Martin, J.C. Broen, F.D. Carmona, M. Teruel, C.P. Simeon, M.C. Vonk, R. van 't Slot, L. Rodriguez-Rodriguez, E. Vicente, V. Fonollosa Spanish Scleroderma Group Identification of CSK as a systemic sclerosis genetic risk factor through Genome wide Association Study follow-up Hum. Mol. Genet. 21 2012 2825 2835
13. J.E. Martin, S. Assassi, L.M. Diaz-Gallo, J.C. Broen, C.P. Simeon, I. Castellvi, E. Vicente-Rabaneda, V. Fonollosa, N. Ortego-Centeno, M.A. González-Gay Spanish Scleroderma Group SLEGEN consortium U.S. Scleroderma GWAS group BIOLUPUS A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci Hum. Mol. Genet. 22 2013 4021 4029
14. A. Cortes, and M.A. Brown Promise and pitfalls of the Immunochip Arthritis Res. Ther. 13 2011 101
15. C. Polychronakos Fine points in mapping autoimmunity Nat. Genet. 43 2011 1173 1174
16. G. Trynka, K.A. Hunt, N.A. Bockett, J. Romanos, V. Mistry, A. Szperl, S.F. Bakker, M.T. Bardella, L. Bhaw-Rosun, G. Castillejo Spanish Consortium on the Genetics of Coeliac Disease (CEGEC) PreventCD Study Group Wellcome Trust Case Control Consortium (WTCCC) Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease Nat. Genet. 43 2011 1193 1201
17. S. Eyre, J. Bowes, D. Diogo, A. Lee, A. Barton, P. Martin, A. Zhernakova, E. Stahl, S. Viatte, K. McAllister Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate Wellcome Trust Case Control Consortium High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis Nat. Genet. 44 2012 1336 1340
18. J.D. Cooper, M.J. Simmonds, N.M. Walker, O. Burren, O.J. Brand, H. Guo, C. Wallace, H. Stevens, G. Coleman, J.A. Franklyn Wellcome Trust Case Control Consortium Seven newly identified loci for autoimmune thyroid disease Hum. Mol. Genet. 21 2012 5202 5208
19. L.C. Tsoi, S.L. Spain, J. Knight, E. Ellinghaus, P.E. Stuart, F. Capon, J. Ding, Y. Li, T. Tejasvi, J.E. Gudjonsson Collaborative Association Study of Psoriasis (CASP) Genetic Analysis of Psoriasis Consortium Psoriasis Association Genetics Extension Wellcome Trust Case Control Consortium 2 Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity Nat. Genet. 44 2012 1341 1348
20. J.Z. Liu, M.A. Almarri, D.J. Gaffney, G.F. Mells, L. Jostins, H.J. Cordell, S.J. Ducker, D.B. Day, M.A. Heneghan, J.M. Neuberger UK Primary Biliary Cirrhosis (PBC) Consortium Wellcome Trust Case Control Consortium 3 Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis Nat. Genet. 44 2012 1137 1141
21. B.D. Juran, G.M. Hirschfield, P. Invernizzi, E.J. Atkinson, Y. Li, G. Xie, R. Kosoy, M. Ransom, Y. Sun, I. Bianchi Italian PBC Genetics Study Group Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants Hum. Mol. Genet. 21 2012 5209 5221
22. A. Hinks, J. Cobb, M.C. Marion, S. Prahalad, M. Sudman, J. Bowes, P. Martin, M.E. Comeau, S. Sajuthi, R. Andrews Boston Children's JIA Registry British Society of Paediatric and Adolescent Rheumatology (BSPAR) Study Group Childhood Arthritis Prospective Study (CAPS) Childhood Arthritis Response to Medication Study (CHARMS) German Society for Pediatric Rheumatology (GKJR) JIA Gene Expression Study NIAMS JIA Genetic Registry TREAT Study United Kingdom Juvenile Idiopathic Arthritis Genetics Consortium (UKJIAGC) Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis Nat. Genet. 45 2013 664 669
23. J.Z. Liu, J.R. Hov, T. Folseraas, E. Ellinghaus, S.M. Rushbrook, N.T. Doncheva, O.A. Andreassen, R.K. Weersma, T.J. Weismüller, B. Eksteen UK-PSCSC Consortium International IBD Genetics Consortium International PSC Study Group Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis Nat. Genet. 45 2013 670 675
24. J. Faraco, L. Lin, B.R. Kornum, E.E. Kenny, G. Trynka, M. Einen, T.J. Rico, P. Lichtner, Y. Dauvilliers, and I. Arnulf et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy PLoS Genet. 9 2013 e1003270
25. D. Ellinghaus, H. Baurecht, J. Esparza-Gordillo, E. Rodríguez, A. Matanovic, I. Marenholz, N. Hübner, H. Schaarschmidt, N. Novak, and S. Michel et al. High-density genotyping study identifies four new susceptibility loci for atopic dermatitis Nat. Genet. 45 2013 808 812
26. A. Cortes, J. Hadler, J.P. Pointon, P.C. Robinson, T. Karaderi, P. Leo, K. Cremin, K. Pryce, J. Harris, S. Lee International Genetics of Ankylosing Spondylitis Consortium (IGAS) Australo-Anglo-American Spondyloarthritis Consortium (TASC) Groupe Française d'Etude Génétique des Spondylarthrites (GFEGS) Nord-Trøndelag Health Study (HUNT) Spondyloarthritis Research Consortium of Canada (SPARCC) Wellcome Trust Case Control Consortium 2 (WTCCC2) Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci Nat. Genet. 45 2013 730 738
27. G. Saruhan-Direskeneli, T. Hughes, K. Aksu, G. Keser, P. Coit, S.Z. Aydin, F. Alibaz-Oner, S. KamalI, M. Inanc, and S. Carette et al. Identification of multiple genetic susceptibility loci in Takayasu arteritis Am. J. Hum. Genet. 93 2013 298 305
28. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Arthritis Rheum. 23 1980 581 590
29. J.D. Reveille, M. Fischbach, T. McNearney, A.W. Friedman, M.B. Aguilar, J. Lisse, M.J. Fritzler, C. Ahn, F.C. Arnett GENISOS Study Group Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants Semin. Arthritis Rheum. 30 2001 332 346
30. A.D. Skol, L.J. Scott, G.R. Abecasis, and M. Boehnke Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies Nat. Genet. 38 2006 209 213
31. S.N.B. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, D. Bender, J. Maller, P. Sklar, P.I. de Bakker, M.J. Daly, and P.C. Sham PLINK: a tool set for whole-genome association and population-based linkage analyses Am. J. Hum. Genet. 81 2007 559 575
32. P.I. de Bakker, M.A. Ferreira, X. Jia, B.M. Neale, S. Raychaudhuri, and B.F. Voight Practical aspects of imputation-driven meta-analysis of genome-wide association studies Hum. Mol. Genet. 17 R2 2008 R122 R128
33. B.N. Howie, P. Donnelly, and J. Marchini A flexible and accurate genotype imputation method for the next generation of genome-wide association studies PLoS Genet. 5 2009 e1000529
34. G.R. Abecasis, D. Altshuler, A. Auton, L.D. Brooks, R.M. Durbin, R.A. Gibbs, M.E. Hurles, G.A. McVean 1000 Genomes Project Consortium A map of human genome variation from population-scale sequencing Nature 467 2010 1061 1073
35. W.M. Brown, J. Pierce, J.E. Hilner, L.H. Perdue, K. Lohman, L. Li, R.B. Venkatesh, S. Hunt, J.C. Mychaleckyj, P. Deloukas Type 1 Diabetes Genetics Consortium Overview of the MHC fine mapping data Diabetes Obes. Metab. 11 Suppl 1 2009 2 7
36. P.I. de Bakker, G. McVean, P.C. Sabeti, M.M. Miretti, T. Green, J. Marchini, X. Ke, A.J. Monsuur, P. Whittaker, and M. Delgado et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC Nat. Genet. 38 2006 1166 1172
37. S.R. Browning, and B.L. Browning Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering Am. J. Hum. Genet. 81 2007 1084 1097
38. X. Jia, B. Han, S. Onengut-Gumuscu, W.M. Chen, P.J. Concannon, S.S. Rich, S. Raychaudhuri, and P.I. de Bakker Imputing amino acid polymorphisms in human leukocyte antigens PLoS ONE 8 2013 e64683
39. F.C. Arnett, P. Gourh, S. Shete, C.W. Ahn, R.E. Honey, S.K. Agarwal, F.K. Tan, T. McNearney, M. Fischbach, and M.J. Fritzler et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls Ann. Rheum. Dis. 69 2010 822 827
40. D.R. Karp, N. Marthandan, S.G. Marsh, C. Ahn, F.C. Arnett, D.S. Deluca, A.D. Diehl, R. Dunivin, K. Eilbeck, and M. Feolo et al. Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis Hum. Mol. Genet. 19 2010 707 719
41. I. Adzhubei, D.M. Jordan, and S.R. Sunyaev Predicting functional effect of human missense mutations using PolyPhen-2 Curr. Protoc. Hum. Genet. Chapter 7 2013 20
42. A.P. Boyle, E.L. Hong, M. Hariharan, Y. Cheng, M.A. Schaub, M. Kasowski, K.J. Karczewski, J. Park, B.C. Hitz, and S. Weng et al. Annotation of functional variation in personal genomes using RegulomeDB Genome Res. 22 2012 1790 1797
43. T.P. Yang, C. Beazley, S.B. Montgomery, A.S. Dimas, M. Gutierrez-Arcelus, B.E. Stranger, P. Deloukas, and E.T. Dermitzakis Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies Bioinformatics 26 2010 2474 2476
44. H.J. Westra, M.J. Peters, T. Esko, H. Yaghootkar, C. Schurmann, J. Kettunen, M.W. Christiansen, B.P. Fairfax, K. Schramm, and J.E. Powell et al. Systematic identification of trans eQTLs as putative drivers of known disease associations Nat. Genet. 45 2013 1238 1243
45. E.F. Pettersen, T.D. Goddard, C.C. Huang, G.S. Couch, D.M. Greenblatt, E.C. Meng, and T.E. Ferrin UCSF Chimera - a visualization system for exploratory research and analysis J. Comput. Chem. 25 2004 1605 1612
46. F.D. Carmona, J.E. Martin, L. Beretta, C.P. Simeón, P.E. Carreira, J.L. Callejas, M. Fernández-Castro, L. Sáez-Comet, E. Beltrán, M.T. Camps Spanish Scleroderma Group The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis PLoS ONE 8 2013 e54419
47. R. Sharif, M.D. Mayes, F.K. Tan, O.Y. Gorlova, L.K. Hummers, A.A. Shah, D.E. Furst, D. Khanna, J. Martin, and L. Bossini-Castillo et al. IRF5 polymorphism predicts prognosis in patients with systemic sclerosis Ann. Rheum. Dis. 71 2012 1197 1202
48. P. Dieude, K. Dawidowicz, M. Guedj, Y. Legrain, J. Wipff, E. Hachulla, E. Diot, J. Sibilia, L. Mouthon, and J. Cabane et al. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity J. Rheumatol. 37 2010 987 992
49. I. Ito, Y. Kawaguchi, A. Kawasaki, M. Hasegawa, J. Ohashi, K. Hikami, M. Kawamoto, M. Fujimoto, K. Takehara, and S. Sato et al. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population Arthritis Rheum. 60 2009 1845 1850
50. P. Dieudé, M. Guedj, J. Wipff, J. Avouac, I. Fajardy, E. Diot, B. Granel, J. Sibilia, J. Cabane, and L. Mouthon et al. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis Arthritis Rheum. 60 2009 225 233
51. P. Gourh, S.K. Agarwal, D. Divecha, S. Assassi, G. Paz, R.K. Arora-Singh, J.D. Reveille, S. Shete, M.D. Mayes, F.C. Arnett, and F.K. Tan Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines Arthritis Rheum. 60 2009 3794 3806
52. P. Dieudé, M. Guedj, J. Wipff, B. Ruiz, E. Hachulla, E. Diot, B. Granel, J. Sibilia, K. Tiev, and L. Mouthon et al. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis Arthritis Rheum. 60 2009 2472 2479
53. N. Tsuchiya, A. Kawasaki, M. Hasegawa, M. Fujimoto, K. Takehara, Y. Kawaguchi, M. Kawamoto, M. Hara, and S. Sato Association of STAT4 polymorphism with systemic sclerosis in a Japanese population Ann. Rheum. Dis. 68 2009 1375 1376
54. B. Rueda, J. Broen, C. Simeon, R. Hesselstrand, B. Diaz, H. Suárez, N. Ortego-Centeno, G. Riemekasten, V. Fonollosa, and M.C. Vonk et al. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype Hum. Mol. Genet. 18 2009 2071 2077
55. A. Bellemare-Pelletier, J. Tremblay, S. Beaulieu, M.R. Boulassel, J.P. Routy, B. Massie, R. Lapointe, and J. Thibodeau HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing J. Leukoc. Biol. 78 2005 95 105
56. S. Bahram, D. Arnold, M. Bresnahan, J.L. Strominger, and T. Spies Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region Proc. Natl. Acad. Sci. USA 88 1991 10094 10098
57. J.H. Brown, T.S. Jardetzky, J.C. Gorga, L.J. Stern, R.G. Urban, J.L. Strominger, and D.C. Wiley Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 Nature 364 1993 33 39
58. S. Tollefsen, K. Hotta, X. Chen, B. Simonsen, K. Swaminathan, I.I. Mathews, L.M. Sollid, and C.Y. Kim Structural and functional studies of trans-encoded HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) protein molecule J. Biol. Chem. 287 2012 13611 13619
59. S. Dai, G.A. Murphy, F. Crawford, D.G. Mack, M.T. Falta, P. Marrack, J.W. Kappler, and A.P. Fontenot Crystal structure of HLA-DP2 and implications for chronic beryllium disease Proc. Natl. Acad. Sci. USA 107 2010 7425 7430
60. W.F. Baron, C.Q. Pan, S.A. Spencer, A.M. Ryan, R.A. Lazarus, and K.P. Baker Cloning and characterization of an actin-resistant DNase I-like endonuclease secreted by macrophages Gene 215 1998 291 301
61. D. Shiokawa, and S. Tanuma Characterization of human DNase I family endonucleases and activation of DNase gamma during apoptosis Biochemistry 40 2001 143 152
62. Y. Errami, A.S. Naura, H. Kim, J. Ju, Y. Suzuki, A.H. El-Bahrawy, M.A. Ghonim, R.A. Hemeida, M.S. Mansy, and J. Zhang et al. Apoptotic DNA fragmentation may be a cooperative activity between caspase-activated deoxyribonuclease and the poly(ADP-ribose) polymerase-regulated DNAS1L3, an endoplasmic reticulum-localized endonuclease that translocates to the nucleus during apoptosis J. Biol. Chem. 288 2013 3460 3468
63. M. Okamoto, N. Okamoto, H. Yashiro, D. Shiokawa, S. Sunaga, A. Yoshimori, S. Tanuma, and D. Kitamura Involvement of DNase gamma in the resected double-strand DNA breaks in immunoglobulin genes Biochem. Biophys. Res. Commun. 327 2005 76 83
64. S.M. Al-Mayouf, A. Sunker, R. Abdwani, S.A. Abrawi, F. Almurshedi, N. Alhashmi, A. Al Sonbul, W. Sewairi, A. Qari, and E. Abdallah et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus Nat. Genet. 43 2011 1186 1188
65. M. Ueki, H. Takeshita, J. Fujihara, R. Iida, I. Yuasa, H. Kato, A. Panduro, T. Nakajima, Y. Kominato, and T. Yasuda Caucasian-specific allele in non-synonymous single nucleotide polymorphisms of the gene encoding deoxyribonuclease I-like 3, potentially relevant to autoimmunity, produces an inactive enzyme Clin. Chim. Acta 407 2009 20 24
66. Y.S. Gu, J. Kong, G.S. Cheema, C.L. Keen, G. Wick, and M.E. Gershwin The immunobiology of systemic sclerosis Semin. Arthritis Rheum. 38 2008 132 160
67. S. Sato, H. Hanakawa, M. Hasegawa, T. Nagaoka, Y. Hamaguchi, C. Nishijima, K. Komatsu, A. Hirata, and K. Takehara Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis J. Rheumatol. 27 2000 2838 2842
68. A.M. Choi, S.W. Ryter, and B. Levine Autophagy in human health and disease N. Engl. J. Med. 368 2013 1845 1846
69. V. Gateva, J.K. Sandling, G. Hom, K.E. Taylor, S.A. Chung, X. Sun, W. Ortmann, R. Kosoy, R.C. Ferreira, and G. Nordmark et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus Nat. Genet. 41 2009 1228 1233
70. S. Raychaudhuri, B.P. Thomson, E.F. Remmers, S. Eyre, A. Hinks, C. Guiducci, J.J. Catanese, G. Xie, E.A. Stahl, R. Chen BIRAC Consortium YEAR Consortium Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk Nat. Genet. 41 2009 1313 1318
71. D. Ellinghaus, H. Zhang, S. Zeissig, S. Lipinski, A. Till, T. Jiang, B. Stade, Y. Bromberg, E. Ellinghaus, and A. Keller et al. Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies Gastroenterology 145 2013 339 347
72. M. Merkenschlager, and D.T. Odom CTCF and cohesin: linking gene regulatory elements with their targets Cell 152 2013 1285 1297
73. S. de Vries, I.S. Naarmann-de Vries, H. Urlaub, H. Lue, J. Bernhagen, D.H. Ostareck, and A. Ostareck-Lederer Identification of DEAD-box RNA helicase 6 (DDX6) as a cellular modulator of vascular endothelial growth factor expression under hypoxia J. Biol. Chem. 288 2013 5815 5827
74. B.F. Voight, and C. Cotsapas Human genetics offers an emerging picture of common pathways and mechanisms in autoimmunity Curr. Opin. Immunol. 24 2012 552 557 Diseases